CTRI/2023/03/050965
Not yet recruiting
Phase 2
An open randomised Controlled clinical study to evaluate the efficacy of Bhrushtamudga Kashaya in Garbhini Chardi W S R to Emesis Gravidarum
Dr Payal Ishwar Mandhalkar0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: O210- Mild hyperemesis gravidarum
- Sponsor
- Dr Payal Ishwar Mandhalkar
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient with intra uterine pregnancy having signs and symptoms of Garbhini Chardi .
- •Patient diagnosed as Garbhini Chardi in first trimester.
- •Patient irrespective of parity, caste,income group,occupation
Exclusion Criteria
- •Patient with Hyper Emesis Gravidarum.
- •Patient in whom chardi seen in second and third trimester.
- •Vomiting caused due to other systemic disorders like acid peptic disorders, etc.
- •Gestational trophoblastic disease and multiple pregnancy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Clinical study on role of polyherbal combination in treatment of fungal skin inection.Health Condition 1: B354- Tinea corporisCTRI/2024/08/071873Dr Nikhil Joglekar
Not yet recruiting
Phase 2
Clinical Study of Marma Therapy in Low Back Pain.CTRI/2024/01/061286Dr.Suhas Shah
Completed
Not Applicable
Efficacy of a maintenance therapy with supplements containing indole-3-carbinol (I3C) and epigallocatechin-3-gallate (EGCG) in ovarian cancer patientsOvarian cancerCancer - Ovarian and primary peritonealACTRN12616000394448Russian Scientific Center of Roentgenoradiology284
Not yet recruiting
Phase 2
To study the efficacy of garlic milk decoction in decreased breast milk secretion.CTRI/2022/04/042216ALKA SARVAJEET SINGH
Not yet recruiting
Phase 2
A clinical study to evaluate the effects of chandana ghrita between systemic use and akshitarpana in prathama patalgata timira w.s.r. to simple myopiaHealth Condition 1: H531- Subjective visual disturbancesCTRI/2023/01/049116il